2840 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Dahi
    Dahi
  4. Ponce
    Ponce
  5. Shah
    Shah
  6. Sauter
    Sauter
  7. Scordo
    Scordo
  8. Jakubowski
    Jakubowski
  9. Papadopoulos
    Papadopoulos
  10. Devlin
    Devlin

Groups

  1. MSK Grad Students (2840)
  2. GSK Faculty (1991)
  3. Department of Medicine (1592)
  4. Sloan Kettering Institute Postdocs (1579)
  5. Sloan Kettering Institute Faculty (1299)
  6. Center for Hematologic Malignancies (1109)
  7. Hematologic Malignancies, Division of (993)
  8. CTCR Scholars (988)
  9. Master of Science in Clinical and Translational Cancer Research (955)
  10. Epidemiology and Biostatistics (734)
  1. "MSK Grad Students"
Formats
  1. Journal Article (1632)
  2. Meeting Abstract (965)
  3. Review (105)
  4. Editorial (42)
  5. Research Letter (35)
  6. Miscellaneous (19)
  7. Correspondence (15)
  8. Conference Paper (12)
  9. Book Section (9)
  10. Guidelines (6)
Groups
  1. MSK Grad Students (2840)
  2. GSK Faculty (1991)
  3. Department of Medicine (1592)
  4. Sloan Kettering Institute Postdocs (1579)
  5. Sloan Kettering Institute Faculty (1299)
  6. Center for Hematologic Malignancies (1109)

More Groups

People
  1. Sergio Giralt (392)
  2. Miguel-Angel Perales (376)
  3. Parastoo Dahi (294)
  4. Sean Devlin (277)
  5. Doris Ponce (254)
  6. Roni Tamari (208)

More People

Years
  1. 2025 (94)
  2. 2024 (256)
  3. 2023 (312)
  4. 2022 (334)
  5. 2021 (289)
  6. 2020 (378)

More Years

Publications
  1. Blood (294)
  2. Biology of Blood and Marrow Transplantation (165)
  3. Cancer Research (132)
  4. Journal of Clinical Oncology (127)
  5. Nature Communications (96)
  6. Nature (85)

More Publications

Publishers
  1. Nature Publishing Group (435)
  2. American Society of Hematology (331)
  3. Elsevier Inc. (298)
  4. Cell Press (272)
  5. American Association for Cancer Research (265)
  6. American Society of Clinical Oncology (143)

More Publishers

Results (2840)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NOTCH and CAR signaling control T cell lineage commitment from pluripotent stem cells
    Meeting Abstract

    Van der Stegen, S.; Lindenbergh, P.; Petrovic, R.; Whitlock, B.; Clarke, R.; Valamehr, B.; Riviere, I.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • The tumor associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B-cell lymphoma
    Meeting Abstract

    Takata, K.; Chong, L. C.; Ennishi, D.; Thakur, A.; Healy, S.; Viganò€, E.; Dao, T.; Nielsen, J. S.; Ben-Neriah, S.; Aoki, T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation
    Meeting Abstract

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
    Meeting Abstract

    Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Investigational CD47-blocker TTI-622 shows single-agent activity in patients with advanced relapsed or refractory lymphoma: Update from the ongoing first-in-human dose escalation study
    Meeting Abstract

    Patel, K.; Ramchandren, R.; Maris, M.; Lesokhin, A. M.; von Keudell, G. R.; Cheson, B. D.; Zonder, J.; Seymour, E. K.; Catalano, T.; Lin, G. H. Y.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of HLA evolutionary divergence on clinical features of patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria
    Meeting Abstract

    Pagliuca, S.; Gurnari, C.; Chowell, D.; Krishna, C.; Patel, B. J.; Awada, H.; Kerr, C. M.; Kongkiatkamon, S.; Kishtagari, A.; Laframboise, T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Targeted integration of a CAR at a novel genomic safe harbor directs potent therapeutic outcomes
    Meeting Abstract

    Odak, A.; Yuan, H.; Feucht, J.; Mansilla-Soto, J.; Eyquem, J.; Leslie, C.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center biologic assignment trial comparing reduced intensity allogeneic hematopoietic cell transplantation to hypomethylating therapy or best supportive care in patients aged 50-75 with advanced myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102
    Meeting Abstract

    Nakamura, R.; Saber, W.; Martens, M. J.; Ramirez, A.; Scott, B. L.; Oran, B.; Leifer, E.; Tamari, R.; Mishra, A.; Maziarz, R. T.; more...
    Blood (2020)

    Fulltext@MSK | Save